Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

被引:0
|
作者
Sarah L Tansley
Zoe E Betteridge
Harsha Gunawardena
Thomas S Jacques
Catherine M Owens
Clarissa Pilkington
Katie Arnold
Shireena Yasin
Elena Moraitis
Lucy R Wedderburn
Neil J McHugh
机构
[1] Royal National Hospital for Rheumatic Diseases,Department of Pharmacy and Pharmacology
[2] University of Bath,Department of Rheumatology
[3] North Bristol NHS Trust,Department of Histopathology, Great Ormond Street Hospital NHS Foundation Trust, London and Neural Development Unit
[4] University College London,Department of Cardiothoracic Radiology
[5] Great Ormond Street Hospital NHS Foundation Trust,Rheumatology Unit
[6] Great Ormond Street Hospital NHS Foundation Trust,undefined
[7] Rheumatology Unit UCL Institute of Child Health,undefined
[8] Rheumatology Unit UCL Institute of Child Health and Arthritis Research UK Centre for Adolescent Rheumatology at UCL,undefined
[9] Royal National Hospital for Rheumatic Diseases,undefined
[10] Bath,undefined
[11] UK Juvenile Dermatomyositis Research Group,undefined
关键词
Interstitial Lung Disease; Myositis; Calcinosis; Chest Imaging; Juvenile Dermatomyositis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
    Sabbagh, Sara
    de Jesus, Adriana Almeida
    Hwang, Sujin
    Kuehn, Hye Sun
    Kim, Hanna
    Jung, Lawrence
    Carrasco, Ruy
    Rosenzweig, Sergio
    Goldbach-Mansky, Raphaela
    Rider, Lisa G.
    BRAIN, 2019, 142 : E59 - +
  • [22] Anti-MDA5 dermatomyositis mimicking psoriatic arthritis
    Cabezas-Rodriguez, Ivan
    Morante-Bolado, Isla
    Brandy-Garcia, Anahy
    Queiro-Silva, Ruben
    Mozo, Lourdes
    Javier Ballina-Garcia, Francisco
    REUMATOLOGIA CLINICA, 2018, 14 (04): : 224 - 226
  • [23] Bosentan for Cutaneous Ulcers in Anti-MDA5 Dermatomyositis
    Combalia, Andrea
    Giavedoni, Priscila
    Tamez, Lorena
    Grau-Junyent, Josep M.
    Mascaro, Jose M., Jr.
    JAMA DERMATOLOGY, 2018, 154 (03) : 371 - 373
  • [24] Relapsing Hematoma Secondary to Anti-MDA5 Dermatomyositis
    Zhu, Fenglin
    Li, Chengyin
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (03) : E17 - E17
  • [25] ANTI-MDA5 POSITIVE DERMATOMYOSITIS: AN EMERGING ENTITY
    Ortiz-Santamaria, V.
    Ponce, A.
    Busquets, N.
    Del Castillo, N.
    Suris, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1289 - 1289
  • [26] Anti-MDA5 dermatomyositis and progressive interstitial pneumonia
    Silveira, M. G.
    Selva-O'Callaghan, A.
    Ramos-Terrades, N.
    Arredondo-Agudelo, K. V.
    Labrador-Horrillo, M.
    Bravo-Masgoret, C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (01) : 49 - 50
  • [27] Hospitalization and Continuity of Care in Anti-MDA5 Dermatomyositis
    Richardson, William Mark
    Shah, Jill T.
    Mazori, Daniel R.
    Caplan, Avrom S.
    Lo Sicco, Kristen I.
    Femia, Alisa N.
    JAMA DERMATOLOGY, 2024, 160 (06) : 674 - 676
  • [28] Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
    Xin Lu
    Qinglin Peng
    Guochun Wang
    Nature Reviews Rheumatology, 2024, 20 (1) : 48 - 62
  • [29] CLINICAL FEATURES OF PATIENTS WITH CLINICALLY AMYOPATHIC DERMATOMYOSITIS WHO HAVE CIRCULATING ANTI-MDA5 AUTOANTIBODIES WITH INTERSTITIAL PNEUMONIA
    Yamaguchi, Koichi
    Yamaguchi, Aya
    Takemura, Masao
    Hara, Kenichiro
    Maeno, Toshitaka
    Hisada, Takeshi
    RESPIROLOGY, 2018, 23 : 154 - 155
  • [30] Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress
    Lu, Xin
    Peng, Qinglin
    Wang, Guochun
    NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (01) : 48 - 62